Antimicrobial agent-56
Antimicrobial agent-56 is an antimicrobial agent that targets the cell membrane of drug-resistant bacteria. Antimicrobial agent-56 disrupts the cell membrane integrity of methicillin-resistant Staphylococcus aureus (MRSA) via membrane targeting, downregulates lipoteichoic acid biosynthesis and two-component system signaling, inhibits MRSA biofilm formation and eradicates mature biofilms, with a MIC of 6.25 μg/mL. Antimicrobial agent-56 hardly induces drug resistance, exhibits low hemolytic activity, inhibits NO production stimulated by LPS (HY-D1056), and retains the anti-inflammatory activity of Resveratrol (HY-16561). Antimicrobial agent-56 loaded in PVA-SA hydrogel promotes the healing of MRSA-infected wounds and suppresses inflammation. Antimicrobial agent-56 can be used in studies related to MRSA infections.
For research use only. We do not sell to patients.
- Formula: C28H41BrN2O4
- Molecular Weight:549.54
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Antimicrobial agent-56 (compound III-5) shows a MIC of 6.25 μg/mL against methicillin-resistant Staphylococcus aureus (MRSA)[1].
Antimicrobial agent-56 (25-50 μg/mL; 2-4 h) exhibits rapid, concentration- and time-dependent bactericidal activity against MRSA[1].
Antimicrobial agent-56 (serially passaged for 15 times, 24 h per passage) consistently maintains an MIC of 6.25 μg/mL against MRSA, with no detectable drug resistance induced [1].
Antimicrobial agent-56 (3.13 μg/mL; 24 h) inhibits MRSA biofilm formation by more than 80%[1].
Antimicrobial agent-56 (50 μg/mL; 24 h) exhibits a clearance rate of over 90% against mature MRSA biofilms pre-incubated for 12 h[1].
Antimicrobial agent-56 (12.5-50 μg/mL; 5 min) induces plasma membrane depolarization in MRSA (detected using the DiSC3-5/SYTOX Green fluorescent probe), with the fluorescence intensity increasing in a concentration-dependent manner, while the control group remains stable[1].
Antimicrobial agent-56 (50 μg/mL; 4 h) treatment results in over 95% PI-positive MRSA as detected by DAPI/PI double staining, indicating disruption of membrane integrity in the vast majority of bacteria, accompanied by dose-dependent leakage of intracellular DNA and proteins[1].
Antimicrobial agent-56 (1.56-25 μg/mL; 24 h) exhibits no significant cytotoxicity against HEK293 human embryonic kidney cells[1].
Antimicrobial agent-56 (25-200 μM; 24 h) exhibits significant cytotoxicity against RAW 264.7 cells at high concentrations, so 50 μM is selected as the safe working concentration for anti-inflammatory experiments[1].
Antimicrobial agent-56 (100-2000 μg/mL; 1 h) shows an HC50 of 843.9 μg/mL and an SI of 135.02 in the hemolysis assay[1].
Antimicrobial agent-56 (50 μM; 18-24 h) significantly inhibits nitric oxide (NO) production in LPS (HY-D1056)-stimulated RAW 264.7 mouse macrophages, retaining the potent anti-inflammatory activity of Resveratrol (HY-16561)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HEK293 cells
-
Concentration:1.56, 3.13, 6.25, 12.5, 25 μg/mL
-
Incubation Time:24 h
-
Result:Showed no significant cytotoxicity towards HEK293 human embryonic kidney cells.
-
Cell Line:RAW 264.7 cells
-
Concentration:25, 50, 100, 200 μM
-
Incubation Time:24 h
-
Result:Exhibited significant cytotoxicity toward RAW 264.7 cells at 100 μM.
50 μM was selected as the safe working concentration for anti-inflammatory experiments.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Kunming (KM) mice (female, 4-6 weeks old, weighing 19-22 g)[1]
-
Dosage:6.25 mg/kg
-
Administration:topical; every other day; 14 days
-
Result:Achieved a 96% wound healing rate by day 14.
Reduced residual viable bacteria in the wound tissue significantly compared to the untreated model group.
Reached a 77.95% collagen area fraction in the wound dermis.
Reduced serum levels of TNF-α, IL-6, and IL-1β by 55.49%, 62.72%, and 53.01% respectively relative to the untreated model group.
Showed only minimal scattered inflammatory cell infiltration in the wound dermis.
Exhibited continuous body weight gain throughout the 14-day observation period with no abnormal systemic weight changes.
Presented intact, normal tissue architecture with no detectable toxic pathological alterations in H&E-stained sections of the heart, liver, spleen, lungs, and kidneys.
Chemical Information
-
Molecular Weight 549.54
-
Formula C28H41BrN2O4
-
SMILES
C[N+](C)(CC(NCCCCCC)=O)CCCCOC1=CC=C(/C=C/C2=CC(O)=CC(O)=C2)C=C1.[Br-]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
3D Hydrogel Synthetic Scaffold Culture
3D hydrogel synthetic scaffold culture embeds cells, spheroids, organoids, or tissue fragments inside a hydrated crosslinked polymer network so that cells receive matrix and cell-cell cues in three dimensions rather than from a flat plastic surface. A literature-supported model protocol is PEG-4MAL hydrogel culture, in which four-arm maleimide-terminated PEG is functionalized with cysteine-containing adhesive peptides such as RGD and crosslinked with protease-degradable peptides such as GPQ-W; this creates a defined, modular scaffold that supports human organoid generation and culture. The readouts are scaffold-supported growth, morphology, lumen formation, budding, viability, proliferation, lineage-marker expression, and matrix-dependent expansion or differentiation; reported assays include transmitted-light imaging, immunofluorescence, in situ hybridization, qRT-PCR, and rheological characterization.
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Cotton Pellet Granuloma
Cotton pellet granuloma is a classical in vivo chronic inflammation model used to evaluate the anti-inflammatory potential of test substances by measuring their ability to inhibit granuloma tissue formation around an implanted foreign body (cotton pellet) in rodents. The method is based on the biological response to a sterile implanted material, which induces proliferative phase inflammation characterized by fibroblast proliferation and collagen-rich granuloma formation, and the final readout reflects the extent of chronic inflammatory tissue growth surrounding the pellet. In multiple preclinical pharmacological evaluations, inhibition of cotton pellet-induced granuloma formation has been used as an indicator of anti-inflammatory activity in both synthetic and natural product screening contexts.
-
Carrageenan-Induced Paw Edema
Carrageenan-induced paw edema is an acute inflammation model in which intraplantar injection of carrageenan induces localized inflammatory swelling characterized by vascular permeability, leukocyte infiltration, and production of inflammatory mediators such as prostaglandins and cytokines, making it widely used to evaluate anti-inflammatory agents in vivo. The resulting paw volume or thickness increase is quantified over time as a direct readout of inflammatory intensity and drug efficacy, typically reflecting cyclooxygenase-mediated prostaglandin-driven edema formation and immune cell recruitment in peripheral tissue[20].
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Fungal Biofilm Culture
Fungal biofilm culture is an in vitro method for growing surface-attached fungal communities, most commonly Candida albicans, on abiotic substrates such as polystyrene wells, silicone elastomer, or polymethylmethacrylate; the assay models adhesion, proliferation, filamentation, extracellular-matrix-associated maturation, and dispersion. Biofilm output can be read by optical density at 600 nm for adherent biomass, XTT reduction for metabolic activity, CFU recovery for viable attached or dispersed cells, and microscopy for architecture.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Antimicrobial agent-56
- Antimicrobial agent56
- Antimicrobial agent 56
- Bacterial
- MRSA
- PVA-SA hydrogel
- Gram-positive bacterial cell walls
- murine MRSA-infected wound model
- pro-inflammatory cytokine
- biofilm formation
- teichoic acid biosynthesis pathway
- nitric oxide
- lipoteichoic acid biosynthesis
- bacterial two-component system
- Inhibitor
- inhibitor
- inhibit